Ukraine Parliament Votes to Legalize Medical Marijuana

Regulations by 2FIRSTS.ai

Dec.22.2023

Ukraine Parliament Votes to Legalize Medical Marijuana

Ukraine's Parliament votes to legalize medical marijuana following war-related PTSD cases, with strict control on production and sales.

On December 21st, the Ukrainian Parliament voted in favor of legalizing medical cannabis, following a war with Russia that has resulted in thousands of people suffering from post-traumatic stress disorder. Many believe that this condition can be alleviated through medication, according to a report by the Associated Press.

The new law will come into effect six months from now, allowing for the scientific and industrial use of marijuana. It was passed in the Kiev Parliament with 248 votes out of the 401 seats. Details of the voting were not provided at the time. The law was proposed by Prime Minister Denys Smyhal.

The possibility of legalizing medical cannabis has been a long-standing debate in Ukraine. Many people endorse the benefits of cannabis for medical treatment, while others express concerns that legalizing medical marijuana may result in an influx of drugs into Ukrainian urban streets.

The measure imposes strict control over the production and sale of marijuana. Any medication containing cannabis derivatives requires a prescription from a doctor. The recreational use of marijuana remains classified as a criminal offense.

References:

[1] Ucrania aprueba legalizar marihuana medicinal, luego de que guerra causara estrés a miles Agencias

Also Read:

[1] Controversy Surrounding the Legalization of Marijuana in Colombia

[2] Controversial Revisions Proposed for Ohio's Marijuana Legalization Initiative

[3] Ohio Voters Approve Proposal to Legalize Recreational Marijuana

[4] Health Problems on the Rise Since Cannabis Legalization

#Europe #Legislation #UK #CBD #Ukraine #The United Kingdom #Marijuana #European Parliament #Medical marijuana dispensary

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK Experts Raise Concerns Over High-Dose Nicotine Pouches Amid Rising Sales

According to The Guardian, health experts in the UK are warning about the potential health effects of high-dose nicotine pouches as their sales continue to rise. Recent studies show teenagers reporting nicotine rushes, sickness and fainting, while researchers say packaging and marketing increasingly appeal to younger age groups. Although viewed as less harmful than cigarettes, experts remain concerned about their use among non-smokers, especially adolescents.

Nov.13 by 2FIRSTS.ai

BAT Korea Announces Fall Promotion for glo™ hyper Series, Price Reductions up to 40%

BAT Rothmans introduces "glo hyper" series promotion in South Korea, with "glo hyper pro" for $20 and "glo hyper" for $14.

Oct.15 by 2FIRSTS.ai

Virginia Seeks to Dismiss E-Cigarette Ban Challenge, Citing Lack of Legal Standing

The Virginia Attorney General and tax commissioner have urged a federal court to dismiss a lawsuit challenging the state’s ban on unapproved e-cigarettes, arguing that the companies behind the suit lack legal standing since their products are federally illegal. The state contends the plaintiffs, Novo Distro Inc. and Tobacco Hut and Vape Fairfax Inc., have no lawful right to sell unapproved vapes and cannot show irreparable harm.

Dec.10 by 2FIRSTS.ai

Energy Marketers of America Backs White House Crackdown on Illicit Vape Shops, Urges Cleanup of ‘Gray Area’ Market

The Energy Marketers of America (EMA) has publicly endorsed the White House’s enforcement campaign against illicit vape shops, saying it will help address the regulatory “gray area” that has emerged since 2020 due to delayed product approvals. EMA noted that a large volume of unauthorized imported disposable e-cigarettes worth about $86.5 million has been seized and called for stronger, more localized enforcement efforts to ease the burden on compliant convenience retailers.